Our Science

Powerful innovation to transform MS

We're committed to rigorous and ongoing evaluation.

The Impact of Octave’s Clinical Insights (a patient support program) on Medication Adherence

Detection of Silent UTI – a Case Study

Variability in Clinical Decision Making for Neurologists Interpreting MS MRI Brain Reports

CMSC 2023 The Impact of Octave’s Clinical Insights (a patient support program) on Medication Adherence

CMSC 2023 Detection of Silent UTI – A Case Study

CMSC 2023 Variability of Longitudinal Standard of Care Brain MRI Scans Ordered By a Single MS Center

Disease Modifying Therapy in Newly Diagnosed People with Multiple Sclerosis – A Real-World Administrative Claims Study

Analytical Validation of a Multi-Protein, Serum-Based Assay for Disease Activity Assessments in Multiple Sclerosis

Real-World Evidence of Tysabri (Natalizumab) Dose Interval Trends in People with Multiple Sclerosis from Administrative Claims Data

1 … 3 4 5 … 9

The Impact of Octave’s Clinical Insights (a patient support program) on Medication Adherence

Detection of Silent UTI – a Case Study

Variability in Clinical Decision Making for Neurologists Interpreting MS MRI Brain Reports

CMSC 2023 The Impact of Octave’s Clinical Insights (a patient support program) on Medication Adherence

CMSC 2023 Detection of Silent UTI – A Case Study

CMSC 2023 Variability of Longitudinal Standard of Care Brain MRI Scans Ordered By a Single MS Center

Disease Modifying Therapy in Newly Diagnosed People with Multiple Sclerosis – A Real-World Administrative Claims Study

Analytical Validation of a Multi-Protein, Serum-Based Assay for Disease Activity Assessments in Multiple Sclerosis

Real-World Evidence of Tysabri (Natalizumab) Dose Interval Trends in People with Multiple Sclerosis from Administrative Claims Data